In this study, we treated patient derived GBM cultures with TSA and SAHA and demonstrated their ability to strongly reduce TCF4 levels, as previously shown in colon cancer [15]; thus, impairing cell stemness and even sensitizing them to the standard chemotherapeutic treatment with TMZ. The gene discussed is TCF4; the disease is glioblastoma.